We hypothesized that (a) tau SUVr values increase to varying degrees in AD patients depending on the cortical region considered, (b) tau-PET progression could be correlated with cortical atrophy progression, and (c) tau-PET progression could be associated with cognitive decline in specific domains. The gene discussed is MAPT; the disease is Mental deterioration.